Welcome to our dedicated page for Healthpeak Properties news (Ticker: DOC), a resource for investors and traders seeking the latest updates and insights on Healthpeak Properties stock.
Healthpeak Properties, Inc. (NYSE: DOC) is a fully integrated healthcare-focused REIT and S&P 500 company, and its news flow reflects its role as an owner, operator, and developer of real estate for healthcare discovery and delivery. This page aggregates company news so readers can follow announcements about its medical office, life science, and senior housing platforms.
Healthpeak’s news includes updates on capital allocation and transactions, such as acquisitions of life science campuses and dispositions of fully stabilized outpatient medical buildings. For example, the company has reported approximately $925 million of transaction activity, including the acquisition of a 1.4-million square foot campus on Gateway Boulevard in South San Francisco and outpatient medical dispositions totaling hundreds of millions of dollars. News items also cover negotiations and execution on additional outpatient medical sales, recapitalizations, and loan repayments.
Investors can also find earnings-related news, including announcements of quarterly financial results, guidance ranges for key non-GAAP metrics, and conference call details. The company regularly issues press releases with dates and access information for earnings calls and webcasts, as well as links to supplemental reports and reconciliations of non-GAAP financial measures.
Healthpeak’s news flow further covers strategic initiatives such as the planned IPO of Janus Living, Inc., a senior housing REIT that will own Healthpeak’s 34-community, 10,422-unit senior housing portfolio, with Healthpeak serving as external manager. Additional releases highlight monthly dividend declarations, updates to investor presentations, and the publication of the company’s Corporate Impact Report, which describes its sustainability and governance efforts.
By reviewing this news feed, readers can track Healthpeak’s portfolio strategy, transaction activity, dividend announcements, and key corporate developments over time.
Physicians Realty Trust (NYSE:DOC) announced a quarterly cash dividend of $0.23 per common share for the quarter ending June 30, 2022, marking its 36th consecutive quarterly dividend. The Company noted stable cash flows from medical office buildings amid inflation and economic slowdowns, with strong performance from healthcare tenants. The dividend is payable on July 19, 2022, to shareholders of record on July 5, 2022. Additionally, the Company will report its second-quarter results on August 4, 2022, followed by a conference call at 10:00 a.m. ET.
Summary not available.
Physicians Realty Trust (DOC) reported a strong first quarter of 2022, achieving $130.4 million in total revenue, a 15.0% increase from last year. Net income per share stood at $0.06, while Normalized FFO was $0.27 per share. The Trust completed a $22.0 million investment for a 49% stake in three properties and declared a quarterly dividend of $0.23 per share. Notably, total expenses rose to $116.1 million, up from $95.1 million year-over-year. The portfolio remained strong with a 95% leasing rate, and the company expects continued growth in response to inflationary pressures.
Physicians Realty Trust (NYSE:DOC) has declared a quarterly cash dividend of $0.23 per common share for the quarter ending March 31, 2022, marking the 35th consecutive quarterly dividend. The dividend will be payable on April 14, 2022. The company plans to release its Q1 2022 financial results on May 4, 2022, before the market opens, followed by a conference call at 10:00 a.m. ET to discuss the results. The company emphasizes disciplined capital allocation and the predictability of cash flows from medical office buildings.
On February 22, 2022, Ava E. Lias-Booker was appointed to the Board of Trustees for Physicians Realty Trust (NYSE:DOC), expanding the Board from eight to nine members. Her appointment is effective March 1, 2022, and she will stand for election at the 2022 annual meeting. Ms. Lias-Booker, a seasoned lawyer with over 30 years of experience, is a partner at McGuireWoods LLP, leading their litigation practice in Baltimore. Her expertise includes complex commercial litigation and she emphasizes diversity and inclusion. The Trust's leadership expressed strong confidence in her contributions.
Physicians Realty Trust (DOC) reported its fourth quarter and full year 2021 results, achieving a net income of $0.12 per share and normalized FFO of $0.26 per share. Total revenue increased to $116.1 million, marking a 4.2% rise year-over-year. The company completed $852.2 million in investments during Q4, including the acquisition of the Landmark Portfolio. The portfolio was 95% leased, with a 2.9% growth in cash NOI. A quarterly dividend of $0.23 per share was declared, while general and administrative expenses guidance for 2022 is between $40 million and $42 million.
Physicians Realty Trust (NYSE:DOC) has declared a quarterly cash dividend of $0.23 per common share, marking its 34th consecutive quarterly dividend. The dividend is set for payment on January 18, 2022, to shareholders on record as of January 4, 2022. The Company’s year-to-date acquisitions have surpassed $1.027 billion, significantly enhancing its portfolio of outpatient medical facilities. The fourth quarter earnings release is scheduled for February 23, 2022, to provide further financial insights.
Physicians Realty Trust (NYSE: DOC) has successfully acquired 14 Class-A medical office facilities from Landmark Healthcare Facilities for approximately $750 million. Covering over 1.4 million square feet with a 95% lease rate, the properties are strategically located on or near hospitals. The portfolio is expected to yield a first-year cash return of 4.9%, with 75% of the leased space tied to investment-grade health systems. This acquisition enhances DOC's national presence and establishes new partnerships for future investments.
Physicians Realty Trust (DOC) reported a net income of $22 million for Q3 2021, translating to $0.10 per share. The total revenue for the quarter was $115.3 million, up 5.2% year-over-year. The company also achieved normalized FFO of $0.26 per share. Recent investment activities include $1.04 billion in acquisitions year-to-date and new investments of $108.9 million in Q3. The board declared a dividend of $0.23 per share, paid October 15. Additionally, Moody’s upgraded the company's credit rating from 'Baa3' to 'Baa2'.
Summary not available.